| Status: Medicine does not meet criteria for AWMSG assessment | |
Excluded from appraisal by AWMSG as meets exclusion criterion 15. See AWMSG criteria for appraising a medicine for information. |
|
Medicine details |
|
| Medicine name | catridecacog (Novothirteen®) |
| Formulation | 2500 IU powder and solvent for solution for injection |
| Reference number | 4681 |
| Indication | Treatment of breakthrough bleeding episodes in patients with congenital factor XIII A-subunit deficiency during regular prophylaxis |
| Company | Novo Nordisk Ltd |
| BNF chapter | Nutrition & blood |
| Submission type | N/A |
| Status | Medicine does not meet criteria for AWMSG assessment |
| Date of issue | 13/04/2021 |